Back to GSKView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
2 competitors in Pulmonary Disease, Chronic Obstructive
View Full LandscapeDrug Information
Target Indication
Pulmonary Disease, Chronic Obstructive
Clinical Trial
NCT01313650Last updated: 2/10/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Combined Hepatitis A and B vaccinePhase 3
Hepatitis B
GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix)Phase 3
Infections, Meningococcal
Losmapimod 7.5 mg twice dailyPhase 3
Acute Coronary Syndrome
FluoridePhase 3
Dental Caries
Haemophilus influenzae type b- and meningococcal (vaccine)Phase 3
Haemophilus Influenzae Type b
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts